Rezolute
RZLT
#8956
Rank
HK$1.06 B
Marketcap
HK$11.48
Share price
-86.52%
Change (1 day)
-70.17%
Change (1 year)

P/E ratio for Rezolute (RZLT)

P/E ratio as of December 2025 (TTM): -1.42

According to Rezolute's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.41957. At the end of 2024 the company had a P/E ratio of -3.24.

P/E ratio history for Rezolute from 2012 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-3.2475.97%
2023-1.8428.46%
2022-1.43-72.25%
2021-5.17265.71%
2020-1.41162.65%
2019-0.5378-35.47%
2018-0.8333-57.96%
2017-1.9857.1%
2016-1.26-59.92%
2015-3.1563.7%
2014-1.92-55.62%
2013-4.33

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Onconova Therapeutics
ONTX
-0.9953-29.89%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-5.69 300.65%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.